Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0001209191-23-007827

EVP, Global Research and CSO sold 1,304 shares at an average $306.00 ($399,022)

  • EVP, Global Research and CSO acquired 1,304 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ALTSHULER DAVID · EVP, Global Research and CSO

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-06 Exercise or conversion : show line 1 in the form +1,304 $187.53 $244,539 69,949 D
2023-02-06 Sale : show line 2 in the form −12 $300.39 $3,605 69,937 D
2023-02-06 Sale : show line 3 in the form −70 $302.00 $21,140 69,867 D
2023-02-06 Sale : show line 4 in the form −100 $303.64 $30,364 69,767 D
2023-02-06 Sale : show line 5 in the form −349 $305.08 $106,473 69,418 D
2023-02-06 Sale : show line 6 in the form −620 $306.70 $190,154 68,798 D
2023-02-06 Sale : show line 7 in the form −153 $309.06 $47,286 68,645 D
Open-market sales · 1,304 sh · avg $306.00 · $399,022

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-02-06 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −1,304 $187.53 2029-02-05 1,304 0 D
Loading xslF345X03/doc4.xml…